Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands
Compare duration of mechanical ventilation (MV), weaning time, ICU-LOS (ICU-LOS), efficacy and safety of remifentanil-based regimen with conventional sedation and analgesia.
Centre randomised, open-label, crossover, ‘real-life’ study.
15 Dutch hospitals.
Adult medical and post-surgical ICU patients with anticipated short-term (2–3 days) MV.
Patient cohorts were randomised to remifentanil-based regimen (n = 96) with propofol as required, for a maximum of 10 days, or to conventional regimens (n = 109) of propofol, midazolam or lorazepam combined with fentanyl or morphine.
Measurements and main results
Outcomes were weaning time, duration of MV, ICU-LOS, sedation- and analgesia levels, intensivist/ICU nurse satisfaction, adverse events, mean arterial pressure, heart rate. Median duration of ventilation (MV) was 5.1 days with conventional treatment versus 3.9 days with remifentanil (NS). The remifentanil-based regimen reduced median weaning time by 18.9 h (P = 0.0001). Median ICU-LOS was 7.9 days versus 5.9 days, respectively (NS). However, the treatment effects on duration of MV and ICU stay were time-dependent: patients were almost twice as likely to be extubated (P = 0.018) and discharged from the ICU (P = 0.05) on day 1–3. Propofol doses were reduced by 20% (P = 0.05). Remifentanil also improved sedation-agitation scores (P < 0.0001) and intensivist/ICU nurse satisfaction (P < 0.0001). All other outcomes were comparable.
In patients with an expected short-term duration of MV, remifentanil significantly improves sedation and agitation levels and reduces weaning time. This contributes to a shorter duration of MV and ICU-LOS.
- Gravel NR, Searle NR, Sahab PG, Carrier M (1999) Sedation in critically ill patients: Practical recommendations. CNS Drugs 11:9–22 CrossRef
- Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL (1993) The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 79:881–892 CrossRef
- Mehta S, Hill NS (2001) Noninvasive ventilation. Am J Respir Crit Care Med 163:540–577
- Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, De Backer D, Dobb G, Fagon J-Y, Gerlach H, Groeneveld J, Macrae D, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C (2007) Year in review in intensive care medicine, 2006. II. Infections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS. Intensive Care Med 33:214–229 CrossRef
- Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, Dobb G, Fagon J-Y, Gerlach H, Groeneveld J, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C, Tasker R (2006) Year in review in intensive care medicine, 2005. II. Infection and sepsis, ventilator-associated pneumonia, ethics, haematology and haemostasis, ICU organisation and scoring, brain injury. Intensive Care Med 32:380–390 CrossRef
- Battershill AJ, Keating GM (2006) Remifentanil: A review of its analgesic and sedative use in the intensive care unit. Drugs 66:365–385 CrossRef
- Criner GJ, Tzouanakis A, Kreimer DT (1994) Overview of improving tolerance of long-term mechanical ventilation. Crit Care Clin 10:845–866
- James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ (1991) Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 259:712–718
- Westmoreland CL, Hoke JF, Sebel PS, Hug CC Jr, Muir KT (1993) Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 79:893–903 CrossRef
- Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL (1995) Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83:968–975 CrossRef
- Michelsen LG, Hug CC Jr (1996) The pharmacokinetics of remifentanil. J Clin Anesth 8:679–682 CrossRef
- Gusmao Vicente F, Polito Lomar F, Melot C, Vincent JL (2004) Can the experienced ICU physician predict ICU-LOS and outcome better than less experienced colleagues? Intensive Care Med 30:655–659 CrossRef
- Bakker J, Mulder P (2006) Remifentanil shortens duration of mechanical ventilation and ICU stay. Intensive Care Med 32(Suppl 1):S86 (Abstract 0320)
- Breen D, Karabinis A, Malbrain M, Morais R, Albrecht S, Jarnvig IL, Parkinson P, Kirkham AJ (2005) Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: A randomised trial [ISRCTN47583497]. Crit Care 9:R200–R210 CrossRef
- Baillard C, Cohen Y, Le Toumelin P, Karoubi P, Hoang P, Ait Kaci F, Cupa M, Fosse JP (2005) Rémifentanil-midazolam versus sufentanil-midazolam pour la sédation prolongée en reanimation. [Remifentanil-midazolam compared to sufentanil-midazolam for ICU long-term sedation]. Ann Fr Anesth Reanim 24:480–486
- Meurant F (2006) Remifentanil versus sufentanyl narco-sedation in a surgical and medical critical care unit with prevention of narcotic induced hyperalgesia: A randomized double blind study [abstract]. Crit Care 10(Suppl. 1):P437 CrossRef
- Muellejans B, Matthey T, Scholpp J, Schill M (2006) Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: A randomised, open-label, pharmacoeconomic trial. Crit Care 10:R91 CrossRef
- Dahaba AA, Grabner T, Rehak PH, List WF, Metzler H (2004) Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: A randomized double blind study. Anesthesiology 101:640–646 CrossRef
- Howie MB, Cheng D, Newman MF, Pierce ET, Hogue C, Hillel Z, Bowdle TA, Bukenya D (2001) A randomized double-blinded multicentre comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery. Anesth Analg 92:1084–1093 CrossRef
- Muellejans B, Lopez A, Cross MH, Bonome C, Morrison L, Kirkham AJ (2004) Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: A randomized, double-blind controlled trial [ISRCTN43755713]. Crit Care 8:R1–R11 CrossRef
- Park G, Lane M, Rogers S, Bassett P (2007) A comparison of hypnotic and analgesic based sedation in a general intensive care unit. Br J Anaesth 98:76–82 CrossRef
- Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477 CrossRef
- Belhadj Amor M, Ouezini R, Lamine K, Barakette M, Labbene I, Ferjani M (2007) Daily interruption of sedation in intensive care unit patients with renal impairment: remifentanil-midazolam compared to fentanyl-midazolam. Ann Fr Anesth Reanim 26:1041–1044
- Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Intensive Care Medicine
Volume 35, Issue 2 , pp 291-298
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Intensive care
- Mechanical ventilation
- Industry Sectors
- Author Affiliations
- 1. Jeroen Bosch Hospital, ’s-Hertogenbosch, The Netherlands
- 2. Gelre Hospitals, Apeldoorn, The Netherlands
- 3. Isala Clinics, Zwolle, The Netherlands
- 4. Rivierenland Hospital, Tiel, The Netherlands
- 5. Gelderse Vallei Hospital, Ede, The Netherlands
- 6. VieCuri Medical Centre North-Limburg, Venlo, The Netherlands
- 7. Department of Intensive Care, Hs-324, Erasmus MC University Medical Centre, P.O Box 2040, 3000 CA, Rotterdam, The Netherlands